Fenisorex

This classification denotes an anorexiant with the molecular formula C16H16FNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) C0P8MP2SR5, chemically known as 1h-2-benzopyran-3-methanamine, 7-fluoro-3,4-dihydro-1-phenyl-, cis- but more generally known as fenisorex, which bears US NIH Compound Identifier 36983. European Medicines Agency schedules Fenisorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07569MIG. The term FENISOREX is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 12 No. 2 1999, List 40). FENISOREX is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule fenisorex under HS 29329985 and SITC 51569. As of Q4 2014, FENISOREX remains US FDA's Preferred Term for this commodity. Fenisorex bears US NLM identifiers UMLS ID C0605359 and NCI Concept Code C65654. SMILES: FC1CC2C(OC(NC)CC2CC1)C1CCCCC1.